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Background. The incremental value of CAC over traditional risk factors to predict cor-
onary vasodilator dysfunction and inherent myocardial blood ﬂow (MBF) impairment is only
scarcely documented (MBF). The aim of this study was therefore to evaluate the relationship
between CAC content, hyperemic MBF, and coronary ﬂow reserve (CFR) in patients under-
going hybrid
15O-water PET/CT imaging.
Methods. We evaluated 173 (mean age 56 ± 10, 78 men) patients with a low to intermediate
likelihood for coronary artery disease (CAD), without a documented history of CAD, undergoing
vasodilator stress
15O-water PET/CT and CAC scoring. Obstructive coronary artery disease was
excluded by means of invasive (n 5 44) or CT-based coronary angiography (n 5 129).
Results. 91 of 173 patients (52%) had a CAC score of zero. Of those with CAC, the CAC
score was 0.1-99.9, 100-399.9, and ‡400 in 31%, 12%, and 5% of patients, respectively. Global
CAC score showed signiﬁcant inverse correlation with hyperemic MBF (r 52 0.32, P < .001).
With increasing CAC score, there was a decline in hyperemic MBF on a per-patient basis [3.70,
3.30, 2.68, and 2.53 mL  min
21  g
21, with total CAC score of 0, 0.1-99.9, 100-399.9, and ‡400,
respectively (P < .001)]. CFR showed a stepwise decline with increasing levels of CAC (3.70,
3.32, 2.94, and 2.93, P < .05). Multivariate analysis, including age, BMI, and CAD risk factors,
revealed that only age, male gender, BMI, and hypercholesterolemia were associated with
reduced stress perfusion. Furthermore, only diabetes and age were independently associated
with CFR.
Conclusion. In patients without signiﬁcant obstructive CAD, a greater CAC burden is
associated with a decreased hyperemic MBF and CFR. However, this association disappeared
after adjustment for traditional CAD risk factors. These results suggest that CAC does not add
incremental value regarding hyperemic MBF and CFR over established CAD risk factors in
patients without obstructive CAD. (J Nucl Cardiol 2012;19:256–64.)
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256INTRODUCTION
The presence of coronary artery calcium (CAC) is a
marker of vascular injury and related to the extent of
coronary atherosclerotic burden.
1-3 Computed tomogra-
phy (CT) is a routinely used and a well-validated
non-invasive imaging modality for the assessment and
quantiﬁcation of coronary atherosclerosis as represented
by CAC.
3Previous studies have showna positive relation
between CAC and the anatomic severity of coronary
artery disease (CAD),
2,4,5 even after correction for tradi-
tional risk factors.
6-8 These risk factors in turn are known
to affect myocardial perfusion, even in the absence of
CAD.
9TheincrementalvalueofCACovertraditionalrisk
factors to predict coronary vasodilator dysfunction and
inherent myocardial blood ﬂow (MBF) impairment is
only scarcely documented.
10-14 Moreover, the results
from these studies are conﬂicting and hampered by small
sample size, varying patients populations, and the use of
suboptimal imaging techniques to quantify MBF.
This study aimed to determine the relationship
between CAC score and MBF in a large clinical cohort
of symptomatic subjects suspected of and with risk
factors for CAD undergoing hybrid
15O-water PET/CT
imaging, in whom obstructive CAD was excluded by
means of invasive (ICA) or CT-based coronary angiog-
raphy (CTCA). In addition, the additive impact of CAC
score on MBF over gender, age, and conventional CAD
risk factors was explored.
METHODS
Patient Population
Data were obtained from a cohort of 249 patients being
clinically evaluated for CAD and therefore referred for CTCA,
CAC-scoring, and PET MBF measurements on a hybrid PET/
CT scanner (Gemini TF 64, Philips Healthcare, Best, The
Netherlands). Patients were referred because of stable (atyp-
ical) angina or an elevated risk for CAD (presence of two or
more risk factors) in the absence of symptoms. Hypertension
was deﬁned as a blood pressure C140/90 mm Hg or the use of
anti-hypertensive medication. Hypercholesterolemia was
deﬁned as total cholesterol level C5 mmol/L or treatment
with cholesterol lowering medication. Patients were classiﬁed
as having diabetes if they were receiving treatment with oral
hypoglycemic drugs or insulin. A positive family history of
CAD was deﬁned by the presence of CAD in ﬁrst-degree
relatives younger than 55 years in men or 65 years in women.
Obstructive CAD was considered to have been ruled out when
either one of the following criteria had been met: (1) absence
of a luminal stenosis of more than 50% at ICA (N.B. Referral
for ICA was left to the discretion of the treating physician); (2)
when ICA was not available, a CTCA of sufﬁcient quality
enabling adequate grading of all major coronary segments
which did not display a stenosis of more than 50%. Exclusion
criteria were atrial ﬁbrillation, second- or third-degree atrio-
ventricular block, symptomatic asthma, pregnancy, or a
documented history of CAD. A history of CAD was deﬁned
as a prior percutaneous coronary intervention, coronary artery
bypass graft surgery, or a previous myocardial infarction. A
total of 173 out of the 249 evaluated patients met these criteria
and are described in the current study (78 men: mean age 55,
range 33-79 years; and 95 women: mean age 57, range
31-84 years). Electrocardiography did not show signs of a
previous myocardial infarction, and echocardiography showed
a normal left ventricular function without wall motion abnor-
malities in all patients. CAD pre-test likelihood was
determined according to the Diamond and Forrester criteria,
15
using percent cutoffs of\13.4%,[87.2%, and in between for
low, high, and intermediate pre-test likelihood, respectively.
PET Imaging
Patients were instructed to refrain from intake of products
containing caffeine or xanthine 24 hours prior to the scan.
After a scout CT for patient positioning and 2 minutes after the
start of intravenous adenosine infusion 140 lg  kg
-1  min
-1,
370 MBq of
15O-water was injected as a 5 mL (0.8 mL  s
-1)
bolus, followed immediately by a 35-mL saline ﬂush
(2 mL  s
-1). A 6-minute emission scan was started simulta-
neously with the administration of
15O-water. This dynamic
scan sequence was followed immediately by a respiration-
averaged low dose CT scan (LD-CT) to correct for attenuation
(55 mAs; rotation time, 1.5 s; pitch, 0.825; collimation,
16 9 0.625; acquiring 20 cm in 37 s) during normal breath-
ing.
16 Adenosine infusion was terminated after the LD-CT.
After an interval of 10 minutes to allow for decay of
radioactivity and washout of adenosine, an identical PET
sequence was performed during resting conditions. Images
were reconstructed using the 3D row action maximum like-
lihood algorithm into 22 frames (1 9 10, 8 9 5, 4 9 10,
2 9 15, 3 9 20, 2 9 30, and 2 9 60 seconds), applying all
appropriate corrections. Parametric MBF images were gener-
ated and quantitative analysis was performed using in-house
developed software, Cardiac VUer.
17,18 MBF was expressed in
mL  min
-1  g
-1 of perfusable tissue and analyzed according
to the 17-segment model of the American Heart Association.
19
In addition to calculating the MBF for the left ventricle as a
whole, MBF was calculated for each of three vascular
territories (LAD, left anterior descending; LCx, left circum-
ﬂex; and RCA, right coronary artery).
CT Imaging
Patients with a stable heart rate below 65 bpm (either
spontaneous or after administration of oral and/or intravenous
metoprolol) underwent a CT scan for calcium scoring and/or
CTCA. A standard scanning protocol was applied, with
64 9 0.625-mm section collimation, 420-ms gantry rotation
time, 120-kV tube voltage, and a tube current of 800 to
1000 mA (for CTCA), and 100 to 120 mA (for calcium
scoring) depending on patients body size. All scans were
performed with electrocardiogram-gated dose modulation to
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during a single breath hold and coronary calciﬁcation was
deﬁned as a plaque with an area of 1.03 mm
2 and a density
C130 HU. The CAC score was calculated according to the
method described by Agatston.
20 After calcium scoring a
CTCA was performed, whereby a bolus of 100-mL iodinated
contrast agent was injected intravenously (5 mL  s
-1) fol-
lowed by a 50 mL NaCl 0.9% ﬂush. All CT-scans were
analyzed with a 3-dimensional workstation (Brilliance, Philips
Medical Systems, Best, The Netherlands) by an experienced
radiologist and cardiologist who were blinded to the PET-
results. The coronary tree was evaluated according to a 16-
segment coronary artery model modiﬁed from the American
Heart Association.
21
Invasive Coronary Angiography
ICA was performed according to standard clinical proto-
cols. The coronary tree was divided to a 16-segment coronary
artery model modiﬁed from the American Heart Association.
21
Signiﬁcant CAD was ruled out when no stenosis was present or
the diameter stenosis was visually scored B50%. All images
were interpreted by at least two experienced interventional
cardiologists.
Data Interpretation
CAC scores were calculated separately for the LAD
(including the left main coronary artery), LCX artery, and RCA
and then summed to provide a total CAC score. Coronary ﬂow
reserve (CFR) was deﬁned as the ratio between hyperemic and
baseline MBF. Coronary vascular resistance (mm Hg  mL 
min
-1  g
-1)duringhyperemiawascalculatedbydividingmean
arterial pressure (MAP) by hyperemic MBF.
22 Furthermore, to
study heterogeneity in MBF, the coefﬁcient of variation (COV)
was calculated on a per patient basis as the ratio of the standard
deviation of the 17 myocardial segments and mean hyperemic
MBF for that patient. Finally, to explore a potential perfusion
decline along the course of the coronary artery from proximal to
distal segments, the longitudinal perfusion gradient was calcu-
lated according to the method previously described by
Hernandez-Pampaloni et al
23 and initially proposed by Gould
et al.
24
Statistical Analysis
Continuous variables are presented as mean values ± SD,
whereas categorical variables are expressed as actual numbers.
For most analyses, we categorized CAC into 4 groups (0, 0.01-
99.9, 100-399.9, and C400) to accommodate the fact that 52 %
of the studied subjects had a CAC score of 0. The ln (CAC
score ? 1) transformation better normalized CAC distribution.
Continuous variables between males and females were com-
pared using the paired or unpaired two-sided Student’s t test, as
appropriate. Comparison of differences in perfusion parame-
ters across increasing levels of CAC score were performed
using one-way analysis of variance (ANOVA) with Bonfer-
roni’s correction for multiple pair-wise comparisons for
localizing the source of the difference. Evaluation of relation-
ships between variables was performed using Spearman’s rank
correlation analysis. Univariable linear regression analyses
were performed to examine the relationship between cardiac
risk factors, age, gender, ln(CAC ? 1) score and change in
hyperemic MBF and CFR. In addition, predictors associated
with hyperemic MBF and CFR, based on evidence from the
literature,
9 were included simultaneously in a multiple linear
regression model using backward elimination. A P value B.05
(two-sided) was considered statistically signiﬁcant. All statis-
tical analysis was performed using SPSS software package
(SPSS 15.0, Chicago, IL).
RESULTS
Signiﬁcant CAD was considered to be ruled out by
ICA(44)andCTCA(129)inallpatients(n = 173).Patient
characteristics are shown in Table 1. The 173 subjects
included had a global baseline MBF of 1.05 ±
0.34 mL  min
-1  g
-1.Duringadenosine-inducedhyper-
emia, MBF increased signiﬁcantly to 3.40 ± 1.19 mL 
min
-1  g
-1 (P\.001). Coronary ﬂow reserve (CFR)
averaged 3.45 ± 1.32. The median CAC score in this
cohort of symptomatic patients was 0 (interquartile range
0-31). Ninety-one of hundred and seventy-three patients
(52%) had a CAC score of zero. Of those with CAC, the
CACscorewas0.1-99.9,100-399.9,andCor=400in31%,
12%, and 5% of patients, respectively.
Hemodynamics
Table 2 summarizes the hemodynamic characteris-
tics. During adenosine-induced hyperemia, heart rate,
Table 1. Patient characteristics (n = 173)
Characteristics
N (%) or
mean ± SD
Age (years) 56 ± 10
Male gender 78 (45%)
BMI (kg  m
-2)2 7 ± 4
Diabetes 36 (21%)
Hypertension 75 (43%)
Hypercholesterolemia 53 (31%)
Smoking history 69 (40%)
Family history 84 (49%)
Reason for referral
Typical angina pectoris 36 (21%)
Atypical angina pectoris 59 (34%)
Non-anginal chest pain 57 (33%)
High risk, no chest discomfort 21 (12%)
Pre-test likelihood of CAD 0.37 ± 0.30
CAD, Coronary artery disease; BMI, body mass index.
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increased signiﬁcantly compared to baseline, whereas no
signiﬁcant changes occurred in diastolic blood pressure.
Per Patient Analysis
Stratiﬁcation of patients into four groups based on
their CAC scores (0, 0.01-99.9, 100-399.9, and C400)
resulted in a comparable global baseline MBF among the
four CAC groups, whereas hyperemic MBF (3.70, 3.30,
2.68, and 2.53 mL  min
-1  g
-1) and CFR (3.70, 3.32,
2.94, and 2.93) gradually decreased with increasing CAC
levels (Figure 1A, B). The COV, as a marker of hetero-
geneity in MBF, was comparable across all CAC score
groupsduringbothresting(P = .27)andstressconditions
(P = .78) (Figure 2A). Furthermore, comparison of
hyperemic MBF in the base-to-apex direction demon-
strated no longitudinal perfusion gradient with increasing
CAC scores (P = .67, Figure 2B). Minimal coronary
vascularresistance(CVR)displayedasigniﬁcantstepwise
increase (P\.001) with increasing total CAC score
(Figure 3A). Spearman’s rank correlations of baseline
MBF, hyperemic MBF, CFR, minimal CVR, and COV of
hyperemic MBF with ln (CAC ? 1) score were -0.08
(P = .27), -0.32 (P\.001), -0.21 (P\.01), 0.33
(P\.001), and -0.05 (P = .54), respectively.
Per Vessel Analysis
In 173 patients, a total of 519 vascular territories
were analyzed. The correlation between per-vessel ln
(CAC ? 1), hyperemic MBF (r =- 0.31, P\.001),
CFR (r =- 0.22, P\.001), and minimal CVR
(r = 0.33, P\.001) was modest but statistically signif-
icant. Furthermore, when grouped according to per-
vessel CAC score, baseline MBF was comparable across
increasing levels of CAC score (P = .18). In addition,
mean hyperemic MBF (3.62, 2.97, 2.66, and
2.35 mL  min
-1  g
-1), CFR (3.65, 3.09, 3.15, and
2.36) progressively declined across increasing CAC
levels (P\.001) (Figure 1C, D). Minimal CVR showed
a stepwise increase across increasing per-vessel CAC
levels (24, 30, 30, and 34 mm Hg  mL  min
-1  g
-1,
respectively, P\.001) (Figure 3B). In addition, hyper-
emic MBF and CFR decreasedwith increasing number of
coronary vessels containing atherosclerosis (Figure 4).
Predictors of Hyperemic MBF and CFR
Univariable regression analyses demonstrated that
age (P\.01), male gender (P\.001), BMI (P\.01),
diabetes (P = .04), hypercholesterolemia (P = .04),
and ln(CAC ? 1) score (P\.001) displayed an inverse
relationship with hyperemic MBF. Furthermore, multi-
variable linear regression analyses were performed with
predictors which were selected based on evidence from
the literature on their association with an impaired
hyperemic MBF or CFR.
9 When these predictors,
including ln(CAC ? 1) score, were put simultaneously
into a multivariable regression model only age, male
gender, BMI, and hypercholesterolemia were identiﬁed
to have an independently negative impact on hyperemic
MBF (Table 3a). In addition, univariable and multivar-
iable regression analyses were performed to identify
predictors of CFR. Univariable analyses showed that age
(P\.01), BMI (P = .03), diabetes (P\.01), hyper-
tension (P = .04), and total ln(CAC ? 1) (P\.01)
were associated with a negative impact on CFR.
Multivariable regression analyses demonstrated that
only age and diabetes were independently correlated
with a diminished CFR (Table 3b).
DISCUSSION
The current study was conducted to explore the
quantitative relationship between CAC and coronary
vasodilator response in patients who were being eval-
uated for CAD by hybrid
15O-water PET/CT. In
symptomatic patients with multiple risk factors and
non-obstructive CAD, CAC score does not add incre-
mental information over age, gender, and traditional risk
factors to predict impairment of hyperemic MBF and
CFR. Of interest, CAC was also not related to hyperemic
perfusion heterogeneity or the longitudinal perfusion
gradient from base to apex.
Table 2. Systemic hemodynamics at baseline
and hyperemia
Parameter Mean value ± SD
Heart rate (bpm)
Baseline 62 ± 10
Hyperemia 81 ± 13*
Systolic blood pressure (mm Hg)
Baseline 113 ± 19
Hyperemia 115 ± 19*
Diastolic blood pressure (mm Hg)
Baseline 60 ± 9
Hyperemia 60 ± 9
Mean arterial pressure (mm Hg)
Baseline 78 ± 11
Hyperemia 78 ± 12
Rate-pressure product
Baseline 7064 ± 2019
Hyperemia 9445 ± 2407*
Bpm, Beats per minute.
* P\.05 vs baseline.
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MBF was not related to the extent of coronary calciﬁ-
cation.
10-13 This observation is not surprising as resting
MBF is modulated in response to myocardial metabolic
demand and remains preserved till the point of a subtotal
coronary stenosis.
25,26 Schindler et al,
14 however, have
documented an inverse relation between CAC and
resting MBF in a cohort of diabetic patients. These
results may be explained by alterations in the hormonal
milieu and insulin levels which are known to affect
resting MBF in the more advanced stages or diabetes
with coronary injury.
27
The negative correlation between the extent of
coronary calcium and hyperemic MBF and ﬂow reserve
is in concordance with prior studies in asymptomatic
controls,patientssuspectedof CAD, anddiabetics.
10,11,28
Only studies including small number of patients or
employing qualitative ﬂow measurements instead of
absolute quantitative MBF measurements have not been
able to reproduce the relation between vasodilator func-
tion and CAC.
12,13 Multivariate analysis revealed that
only age, male gender, BMI, and hypercholesterolemia
wereassociatedwithreducedstressperfusion.Ofinterest,
CAC score was not an independent predictor of a
diminished hyperemic MBF. This is consistent with
previous work showing that CAC score has little incre-
mental value in predicting a diminished vasodilator
response.
10,11 In contrast to the current data, in these
previous studies signiﬁcant CAD was not excluded and
could therefore have contributed to the observed inde-
pendent (weak) relationship between CAC and impaired
MBF. Thus, although CAC isa strong predictor forfuture
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Figure 1. Per-patient (A, B) and per-vessel analysis (C, D). Relationships between coronary artery
calcium (CAC) and A, C myocardial blood ﬂow (MBF), and B, D coronary ﬂow reserve (CFR).
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sclerotic burden, the current results implicate that CAC
score in symptomatic patients with multiple risk factors
and no obstructive epicardial CAD, does not add incre-
mental information regarding MBF over age, gender,
BMI, and established coronary risk factors.
Another aspect of this study was to investigate the
relation between heterogeneity of hyperemic MBF and
CAC as some of the aforementioned studies have
indicated such an relation.
12,14 It was therefore hypoth-
esized that increased levels of calcium may induce
heterogeneity between coronary perfusion territories, on
the one hand, and a longitudinal perfusion gradient from
base to apex, on the other hand. Gould et al
24 initially
introduced the latter concept, where patients with non-
signiﬁcant CAD displayed a gradual longitudinal decline
in hyperemic MBF from base to apex as measured with
13N-ammonia PET. These results were later conﬁrmed
by Hernandez-Pampaloni et al
23 in asymptomatic
patients with an increased risk proﬁle for CAD. Invasive
measurements have indeed demonstrated that a gradual
hyperemic perfusion pressure gradient exists along the
course of mild atherosclerotic coronary arteries.
29 In the
current study, however, there was no relationship
between heterogeneity of hyperemic MBF and CAC.
Moreover, no perfusion gradient was detected between
the mid and the apical sections of the left ventricle with
increasing CAC scores during adenosine-induced hyper-
emia. Several factors may have contributed to these
observations. First, there might be differences between
study populations. In the current study, 52% of patients
displayed no coronary calcium and the lack of longitu-
dinal perfusion gradient may well be explained by the
lack of coronary artery disease in these patients in
contrast to the cohort of patients described by Gould
et al.
24 Second, there are some methodological
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Figure 2. Relationships between coronary artery calcium (CAC) and A coefﬁcient of variation
(COV), and B longitudinal perfusion gradient (mid-ventricular to apical regions).
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Figure 3. Per-patient analysis (A) and per-vessel analysis (B). Relationships between coronary
artery calcium (CAC) and hyperemic coronary vascular resistance (CVR).
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base to apex gradients have been investigated using
13N-ammonia PET almost a decade ago. The scanner
used in the current study, however, is characterized by a
higher spatial resolution and hence less affected by
partial volume effects. Moreover, the modeling proce-
dure of
15O-water incorporates an intrinsic correction for
partial volume effects. As wall thickness progressive
declines from base to apex, part of the observed
longitudinal perfusion gradient may be caused by partial
volume effects. Third, the perfusion gradient was
measured over only a relatively short longitudinal
distance of the left ventricle, i.e., from the mid-ventric-
ular to the apical portion in concordance with
Hernandez-Pampaloni et al.
23 This approach was chosen
to avoid potential inclusion of the outﬂow tract of the
left ventricle in the perfusion estimates. Nevertheless,
when the longitudinal gradient was measured from the
basal to the apical portion, no myocardial perfusion
gradient was demonstrated in the current population
(data not shown). In addition, the limited number of
patients in the group having a CAC score C 400 could
have introduced bias. Further studies in larger popula-
tions are warranted to assess the effect of CAC on MBF
heterogeneity.
Study Limitations
Some limitations of our study that may affect the
current ﬁndings must be acknowledged. Signiﬁcant CAD
was presumed to have been excluded by invasive or CT-
based coronary angiography. The number of routinely
performed invasive coronaryangiographies inthe current
population was limited. Although CTCA is an excellent
tool for ruling out signiﬁcant CAD with a negative
predictive value of 97% to 99%,
30,31 some patients with
hemodynamic signiﬁcant CAD may have been included.
Furthermore, the current data were obtained in predom-
inantly symptomatic patients and therefore the results
may not be extrapolated to, for example, asymptomatic
subjects.Studiesinasymptomaticsubjectshavedisplayed
conﬂicting results and therefore larger studies are war-
ranted to further investigate the relationship between
CAC score and coronary vasodilator function in speciﬁc
subpopulations. Finally, it must be emphasized that for
subgroup analyses the studied patient population was too
small to draw deﬁnite conclusions.
CONCLUSIONS
In patients with an intermediate pre-test likelihood
of CAD and with multiple CAD risk factors there was a
statistically signiﬁcant inverse correlation between
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Figure 4. Relationship between number of vessels containing CAC and myocardial blood ﬂow
(MBF) (A), and B coronary ﬂow reserve.
Table 3. Backward multiple linear regression
analysis with hyperemic MBF (a) and CFR (b) as
the dependent variables
Independent variable b P value
(a)
Age -0.03 \.001
Male gender -1.07 \.001
BMI -0.07 \.001
Hypercholesterolemia -0.36 .04
(b)
Age -0.03 \.01
Diabetes mellitus type II -0.51 .04
After forcing age, gender, BMI, diabetes type II, hyperten-
sion, smoking history, hypercholesterolemia, family history
and ln(CAC ? 1) into the model. Only variables that had a
P B 0.05 were considered in the ﬁnal model. MBF, Myocar-
dial blood ﬂow; CFR, coronary ﬂow reserve; BMI, body mass
index.
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ever, this association disappeared after adjusting for age,
gender, BMI, and conventional risk factors. These
results suggest that CAC score does not add incremental
value regarding hyperemic MBF and CFR over estab-
lished CAD risk factors in patients with an intermediate
pre-test likelihood of CAD and no obstructive epicardial
CAD. Therefore, coronary artery calciﬁcations and
vasodilator reactivity reﬂect different aspects of coro-
nary atherosclerosis.
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